Business
Appointment of COO
Appointment of COO.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n RNS Number : 7507F Advanced Medical Solutions Grp PLC 19 January 2010 \n \n\n\n\n\nFor immediate release\n\n\n 19 January 2010\n\n\n\n\n\n\nAdvanced Medical Solutions Group plc \n(\"AMS\" or \"the Company\")\n\nAppointment of Chief Operating Officer\n\n\nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, announces that Chris Meredith, Group Commercial Director, has been appointed as Chief Operating Officer to better reflect the breadth of his existing role.\n\n\nFor further information, please contact:\n\n\n\n\n\nAdvanced Medical Solutions Group plc\n\n\n\n\n\n\n\nDon Evans, Chief Executive Officer\nMary Tavener, Finance Director\nwww.admedsol.com\n\n\n Tel: +44 (0) 1606 545508\n\n\n\n\n\n\n\n\n\n\n\n\nBuchanan Communications\n\n\n\n\n\n\n\nMark Court / Stasa Filiplic\n\n\nTel: +44 (0) 20 7466 5000\n\n\n\n\n\n\n\n\n\n\n\n\nInvestec Bank plc\n\n\nTel: +44 (0) 20 7597 5970\n\n\n\n\nGary Clarence / Tim Pratelli / Daniel Adams\n\n\n\n\n\n\n\n\nNotes to Editors:\n\nAdvanced Medical Solutions develops and manufactures products for the $15 billion global woundcare market.\n\nFounded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure. \n\nThe advanced woundcare products are based on the moist wound healing principle. AMS uses its in-house technology to provide a vertically integrated 'one stop shop' for all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.\n\nAMS' technology in cyanoacrylate based tissue adhesives is used for the closure of small cuts and trauma wounds through to large surgical incisions, and also for protecting or sealing skin to prevent breakdown or infection. \n\nAMS' products which currently serve the majority of the key global markets are sold either direct or through strategic partners and distributors. \n\n\n\n\n\nThis information is provided by RNSThe company news service from the London Stock Exchange END MSCGGUPUGUPUPUR \n ","length":5422,"tagName":"div"}]